Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label…

By V. Vilgrain, H. Pereira, E. Assenat, B. Guiu, Alina-Diana Ilonca, G. Pageaux, A. Sibert, M. Bouattour, R. Lebtahi, Wassim Allaham and 27 more. The Lancet Oncology, 2017

666 citations recorded by the source corpus.

Subfields: Hepatology, Surgery

View Paper: https://www.semanticscholar.org/paper/753b6a54253332d8b18492155981034075c0ea7a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hepatology

1. Amit G. Singal
2. F. Kanwal
3. J. Llovet
4. Jordi Bruix1 , 2
5. Riccardo Lencioni

In Surgery

1. J. Llovet

Citations in the corpus

• Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy (2023, background): “Two studies of these RCTs, SARAH 224 and”